Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 25Neoplasm Metastasis 6Metastatic Hormone-sensitive Prostate Cancer 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Stage I Prostate Adenocarcinoma 1Salivary Gland Neoplasms 1Recurrence 1Non-metastatic, Hormone naïve Prostate Cancer 1Neoplasms 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Lymphatic Metastasis 1Insulin Resistance 1Adenocarcinoma of the Prostate 1

Interventions

pexidartinib 1Radiotherapy 1Radiosurgery 1Radiation 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Stage I Prostate Adenocarcinoma × Androgen Antagonists × Clear all
NCT02472275 2020-10-06

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed
8 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡